Gene · 442900
Papers2,392
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,392
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Long non-coding RNAs and JAK/STAT signaling pathway regulation in colorectal cancer development. | Front Genet | 2023 | 38094755 | PubTator, text mining | PubMed |
| MicroRNAs as biomarkers for trastuzumab-based therapy in HER2-positive advanced oesophago-gastric cancer patients. | Front Oncol | 2023 | 38094609 | PubTator, text mining | PubMed |
| Long non-coding RNA and Evolving drug resistance in lung cancer. | Heliyon | 2023 | 38089985 | PubTator, text mining | PubMed |
| Circular RNAs: emerging players in asthma and COPD. | Front Cell Dev Biol | 2023 | 38078005 | PubTator, text mining | PubMed |
| Function of macrophage-derived exosomes in chronic liver disease: From pathogenesis to treatment. | World J Hepatol | 2023 | 38075004 | PubTator, text mining | PubMed |
| Identification and validation of telomerase related lncRNAs signature to predict prognosis and tumor immunotherapy response in bladder cancer. | Sci Rep | 2023 | 38071230 | PubTator, text mining | PubMed |
| Adhesion G Protein-Coupled Receptor G2 Promotes Hepatocellular Carcinoma Progression and Serves as a Neutrophil-Related Prognostic Biomarker. | Int J Mol Sci | 2023 | 38069309 | PubTator, text mining | PubMed |
| Bioinformatics analysis-based screening of circRNA gene with mainstream expression trend in colorectal cancer and construction of a coexpression regulatory network. | PLoS One | 2023 | 38064496 | PubTator, text mining | PubMed |
| METTL3/YTHDC1-medicated m6A modification of circRNA3634 regulates the proliferation and differentiation of antler chondrocytes by miR-124486-5-MAPK1 axis. | Cell Mol Biol Lett | 2023 | 38062349 | PubTator, text mining | PubMed |
CircATP13A1 (hsa_circ_0000919) promotes cell proliferation and metastasis and inhibits cell apoptosis in pancreatic ductal adenocarcinoma via the miR-186/miR-326/HMGA2 axis: implications for novel therapeutic targets. | Am J Cancer Res | 2023 | 38058810 | PubTator, text mining | PubMed |
| Comprehensive analysis of miRNA-mRNA regulatory pairs associated with colorectal cancer and the role in tumor immunity. | BMC Genomics | 2023 | 38036953 | PubTator, text mining | PubMed |
| Research progress on the biological basis of Traditional Chinese Medicine syndromes of gastrointestinal cancers. | Heliyon | 2023 | 38027682 | PubTator, text mining | PubMed |
| Simultaneous and rapid colorimetric detection of distinct miRNAs using Split-LAMP. | Front Bioeng Biotechnol | 2023 | 38026864 | PubTator, text mining | PubMed |
| Characterization of lncRNA-associated ceRNA network to uncover novel potential biomarkers in coronary artery disease. | Medicine (Baltimore) | 2023 | 38013355 | PubTator, text mining | PubMed |
| CircTENM3 inhibites tumor progression via the miR-558/RUNX3 axis in prostate cancer. | J Transl Med | 2023 | 38007527 | PubTator, text mining | PubMed |
| MicroRNAs as Molecular Biomarkers for the Characterization of Basal-like Breast Tumor Subtype. | Biomedicines | 2023 | 38002007 | PubTator, text mining | PubMed |
| Phytochemicals Target Multiple Metabolic Pathways in Cancer. | Antioxidants (Basel) | 2023 | 38001865 | PubTator, text mining | PubMed |
| Molecular Biology and Clinical Management of Esophageal Adenocarcinoma. | Cancers (Basel) | 2023 | 38001670 | PubTator, text mining | PubMed |
| Identifying the driver miRNAs with somatic copy number alterations driving dysregulated ceRNA networks in cancers. | Biol Direct | 2023 | 37993951 | PubTator, text mining | PubMed |
| Association of microRNA Polymorphisms with Toxicities Induced by Methotrexate in Children with Acute Lymphoblastic Leukemia. | Hematol Rep | 2023 | 37987321 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442900/papers?page=9